RCKY Q1 2026 Earnings Earnings Miss Consensus Despite Positive Market Response Traws Pharma Q1 2026 Earnings Narrower Than Expected Loss Despite No Revenue Denali Therapeutics Q1 2026 Earnings Narrower Loss Surprises Stock Edges Higher BDCIU Q1 2026 Earnings Positive EPS Despite No Revenue Stock Unchanged ThredUp Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Stock NBIX Q1 2026 Earnings Strong EPS Beat Driven by Operational Strength